6505--GENERAL RADIOPHARMACEUTICALS

The Department of Veterans Affairs Network Contracting Office 2 awarded a sole-source contract, number 36C24226D0037, to Nuclear Diagnostic Products, Inc. on February 24, 2026, for a total value of $959,170.05. This procurement, categorized under NAICS 325412 and PSC 6505, ensures the continued provision of general radiopharmaceuticals, including unit and bulk doses, quality control supplies, and related services. The contract was awarded on a non-competitive basis under FAR 6.302-1 to prevent any interruption in critical nuclear medicine services for veterans. The scope of work requires the daily delivery of radiopharmaceuticals and the provision of sealed radioactive sources for quality control to six VA medical centers within VISN 2 Downstate, located in New York and New Jersey. These facilities include the Bronx, Brooklyn, and Manhattan NYHHCS, Northport VAMC, Castle Point VAHVHCS, and East Orange NJ VAMC. The contractor is responsible for all transportation, labor, and inventory management, and must maintain compliance with federal radiation safety regulations, including the submission of Radiation Safety Officer safety audits. This specific award serves as a short-term bridge contract effective from February 22, 2026, through December 31, 2026, with a planned transition to a multi-year contract beginning January 1, 2027. Acceptance of deliverables occurs upon delivery at the respective destination VA medical centers. Paul Speedling serves as the primary Contracting Officer for this effort.